Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Author: Devon Herrick

Nearly 334,000 Medical Providers Quit in 2021

Posted on October 24, 2022October 24, 2022 by Devon Herrick

Public health experts have long predicted that the United States will increasingly suffer from a shortage of physicians. The Association of American Medical Colleges estimates that the physician shortage could reach 120,000 medical providers by 2034. A new report finds that nearly 334,000 health care providers left the field in 2021. This includes doctors and nurse practitioners.

As a profession, physicians lost the most members, with 117,000 individuals leaving their roles last year, followed by nurse practitioners, which lost 53,295 members and physician assistants, with 22,704 positions vacated, according to a report published Thursday by Definitive Healthcare.

+

Surgeon General Believes Toxic Workplaces are a Public Health Hazard (Seriously?)

Posted on October 21, 2022October 21, 2022 by Devon Herrick

It seems in recent years that the definition of public health has grown to include a lot of things seemingly unrelated to public health. The age-old definition of public health includes combating infectious disease and communicable illnesses. Covid-19 is definitely something that can be passed around, as is influenza. Attempts to control the spread of deadly pathogens falls well within the area of public health.

+

FDA Panel Recommends Withdrawing Premature Birth Drug

Posted on October 20, 2022October 20, 2022 by Devon Herrick

An advisory panel for the U.S. Food and Drug Administration (FDA) voted to recommend revoking approval for a synthetic hormone called Makena. Makena is an obstetrics drug administered as a weekly injection to pregnant women at high risk of premature delivery.

An advisory panel to the Food and Drug Administration voted Wednesday to take a drug intended to prevent premature births off the market, saying that it remains doubtful that the drug works.

The recommendation, in a 14-1 vote, from the agency’s Obstetrics, Reproductive and Urologic Drugs Advisory Committee closed a three-day meeting on the clinical trial evidence supporting Makena, the only drug approved in the U.S. to prevent preterm births.

+

Costa Rican Ex-President Says Public Health is Not About Flashy Investments

Posted on October 19, 2022 by Devon Herrick

Carlos Alvarado Quesada, the former president of Costa Rica, recently participated in a fireside chat at the Harvard School of Public Health. Dean Michelle Williams introduced Alvarado to a small group of faculty and students for the fireside chat. Alvarado guided Costa Rica through the COVID-19 pandemic, which the country was able to weather well due to its strong…

+
  • Previous
  • 1
  • …
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 225
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom